As a contract manufacturer of parenteral products, CBL hosts general inspections by the FDA on an annual basis. With the increase in CBL produced products being distributed internationally, inspections and approvals by foreign regulatory agencies, including the MHRA, EMEA, and JPMD have increased as well.

Below is a snapshot of the inspections completed at CBL’s multi-use facility: